<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao J</submitter><funding>Capital's Funds for Health Improvement and Research of China</funding><funding>Natural Science Foundation of Xiamen City</funding><funding>Capital’s Funds for Health Improvement and Research of China</funding><pagination>19</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9950708</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Non-alcoholic steatohepatitis (NASH) had not yet been approved therapy. Electro-acupuncture (EA) has been reported to have potential efficacy. However, high-quality clinical evidence was still lacking.&lt;h4>Methods&lt;/h4>NASH patients were randomized and allocated to either sham acupuncture (SA) or EA group in a 1:1 ratio, with the patient blinded. Each patient received 36 sessions of SA or EA treatment over 12 weeks, followed by additional 4 weeks. The primary outcome was the changes in relative liver fat content measured by magnetic resonance imaging proton density fat fraction (MRI-PDFF).&lt;h4>Results&lt;/h4>A total of 60 patients were enrolled. From baseline to week 12, the reduction of relative liver fat content measured by MRI-PDFF in the EA group (- 33.6%, quantile range: </pubmed_abstract><journal>Chinese medicine</journal><pubmed_title>Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial.</pubmed_title><pmcid>PMC9950708</pmcid><funding_grant_id>2022-1-2021</funding_grant_id><funding_grant_id>2022-2-20213</funding_grant_id><funding_grant_id>82130018</funding_grant_id><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Cao D</pubmed_authors><pubmed_authors>Du Y</pubmed_authors><pubmed_authors>Tong X</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors><pubmed_authors>Jia J</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Ren H</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Xu S</pubmed_authors><pubmed_authors>Ou X</pubmed_authors><pubmed_authors>Han C</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Duan W</pubmed_authors><pubmed_authors>You H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial.</name><description>&lt;h4>Background&lt;/h4>Non-alcoholic steatohepatitis (NASH) had not yet been approved therapy. Electro-acupuncture (EA) has been reported to have potential efficacy. However, high-quality clinical evidence was still lacking.&lt;h4>Methods&lt;/h4>NASH patients were randomized and allocated to either sham acupuncture (SA) or EA group in a 1:1 ratio, with the patient blinded. Each patient received 36 sessions of SA or EA treatment over 12 weeks, followed by additional 4 weeks. The primary outcome was the changes in relative liver fat content measured by magnetic resonance imaging proton density fat fraction (MRI-PDFF).&lt;h4>Results&lt;/h4>A total of 60 patients were enrolled. From baseline to week 12, the reduction of relative liver fat content measured by MRI-PDFF in the EA group (- 33.6%, quantile range: </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-05T13:20:24.378Z</modification><creation>2025-02-18T23:58:02.017Z</creation></dates><accession>S-EPMC9950708</accession><cross_references><pubmed>36829229</pubmed><doi>10.1186/s13020-023-00724-w</doi></cross_references></HashMap>